Literature DB >> 25491917

Inhibition of iron uptake by ferristatin II is exerted through internalization of DMT1 at the plasma membrane.

Izumi Yanatori1, Yumiko Yasui, Yumiko Noguchi, Fumio Kishi.   

Abstract

Ferristatin II, discovered as an iron transport inhibitor, promotes the internalization and degradation of transferrin receptor 1 (TfR1). DMT1, which mediates iron transport across cell membranes, is located at the plasma membrane of enterocytes and imports dietary iron into the cytosol. TfR1 is not directly engaged in the intestinal absorption of free iron, and iron uptake by DMT1 is attenuated by ferristatin II treatment. In this study, we found another function for ferristatin II in iron uptake. Ferristatin II did not cause degradation of DMT1 but did induce DMT1 internalization from the plasma membrane. Dynasore, a small molecule inhibitor of dynamin, did not inhibit this internalization by ferristatin II, which might occur via a clathrin-independent pathway.
© 2014 International Federation for Cell Biology.

Entities:  

Keywords:  divalent metal transporter 1; ferristatin II; iron uptake

Mesh:

Substances:

Year:  2015        PMID: 25491917     DOI: 10.1002/cbin.10403

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  9 in total

Review 1.  Developing drugs targeting transition metal homeostasis.

Authors:  Claire M Weekley; Chuan He
Journal:  Curr Opin Chem Biol       Date:  2016-12-29       Impact factor: 8.822

2.  Iron Export through the Transporter Ferroportin 1 Is Modulated by the Iron Chaperone PCBP2.

Authors:  Izumi Yanatori; Des R Richardson; Kiyoshi Imada; Fumio Kishi
Journal:  J Biol Chem       Date:  2016-06-14       Impact factor: 5.157

3.  The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer.

Authors:  Izumi Yanatori; Des R Richardson; Shinya Toyokuni; Fumio Kishi
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

4.  Zinc ions have a potential to attenuate both Ni ion uptake and Ni ion-induced inflammation.

Authors:  Ryo Onodera; Sanki Asakawa; Ryosuke Segawa; Natsumi Mizuno; Kouetsu Ogasawara; Masahiro Hiratsuka; Noriyasu Hirasawa
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 5.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.

Authors:  Rikki A M Brown; Kirsty L Richardson; Tasnuva D Kabir; Debbie Trinder; Ruth Ganss; Peter J Leedman
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

Review 6.  Targeting iron metabolism in drug discovery and delivery.

Authors:  Bart J Crielaard; Twan Lammers; Stefano Rivella
Journal:  Nat Rev Drug Discov       Date:  2017-02-03       Impact factor: 84.694

7.  Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.

Authors:  Laura Prieto Clemente; Malena Rabenau; Stephan Tang; Josefina Stanka; Eileen Cors; Jenny Stroh; Carsten Culmsee; Silvia von Karstedt
Journal:  Cells       Date:  2020-10-09       Impact factor: 6.600

8.  Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia.

Authors:  Marina Mantzourani; George P Chrousos; Styliani A Geronikolou; Işil Takan; Athanasia Pavlopoulou
Journal:  Int J Mol Med       Date:  2022-01-21       Impact factor: 4.101

9.  Differences and Interactions in Placental Manganese and Iron Transfer across an In Vitro Model of Human Villous Trophoblasts.

Authors:  Vivien Michaelis; Leonie Aengenheister; Max Tuchtenhagen; Jörg Rinklebe; Franziska Ebert; Tanja Schwerdtle; Tina Buerki-Thurnherr; Julia Bornhorst
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.